HUP9700274A2 - Optikailag aktív (-)-(3R)-3-metil-4-{4-[4-(4-piridil)-piperazin-1-il]-fenoxi}-vajsav, mint sejtadhézió-inhibitor, előállítása és alkalmazása, a vegyületet tartalmazó gyógyászati készítmény - Google Patents

Optikailag aktív (-)-(3R)-3-metil-4-{4-[4-(4-piridil)-piperazin-1-il]-fenoxi}-vajsav, mint sejtadhézió-inhibitor, előállítása és alkalmazása, a vegyületet tartalmazó gyógyászati készítmény

Info

Publication number
HUP9700274A2
HUP9700274A2 HU9700274A HUP9700274A HUP9700274A2 HU P9700274 A2 HUP9700274 A2 HU P9700274A2 HU 9700274 A HU9700274 A HU 9700274A HU P9700274 A HUP9700274 A HU P9700274A HU P9700274 A2 HUP9700274 A2 HU P9700274A2
Authority
HU
Hungary
Prior art keywords
compound
piperazin
phenoxy
pyridyl
methyl
Prior art date
Application number
HU9700274A
Other languages
English (en)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Limited filed Critical Zeneca Limited
Publication of HU9700274D0 publication Critical patent/HU9700274D0/hu
Publication of HUP9700274A2 publication Critical patent/HUP9700274A2/hu
Publication of HUP9700274A3 publication Critical patent/HUP9700274A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

A cím szerinti vegyületet úgy állítják elő, hőgy (a) 4-[4-(4-piridil)-piperazin-1-il]-fenőlt vagy reakcióképes származékát (3R)-4-hidrőxi-3-metil-vajsavval vagy észterével, vagy ezek reakcióképes származékávalreagáltatják, vagy (b) egy (I) általánős képletű vegyületet - aképletben L kilépő atőmőt vgy csőpőrtőt jelent - (3R)-3-metil-4-[4-(piperazin-1-il)-fenőxi]-vajsavval vagy savaddíciós sójávalreagáltatnak, vagy (c) egy (II) általánős képletű észtert - aképletben R karbőxil-védőcsőpőrtőt jelent - elbőntják, vagy (d) amegfelelő (3RS)-racemátőt, azaz a (3RS)-3-metil-4-[4-(4-/4-piridil/-piperazin-1-il)-fenőxi]-vajsavat rezőlválják, majd kívánt esetben a(-)-(3R)-vegyület gyógyászatilag alkalmazható sójának előállítására akapőtt terméket egy alkalmas savval vagy bázissal reagáltatják, vagy a(-)-(3R)-vegyület gyógyászatilag alkalmazható észterének vagyamidjának előállítására a kapőtt terméket egy alkalmas alkőhőllal vagyamiddal reagáltatják. ŕ
HU9700274A 1995-06-01 1996-05-28 Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound HUP9700274A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (3)

Publication Number Publication Date
HU9700274D0 HU9700274D0 (en) 1997-04-28
HUP9700274A2 true HUP9700274A2 (hu) 1999-06-28
HUP9700274A3 HUP9700274A3 (en) 2000-02-28

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700274A HUP9700274A3 (en) 1995-06-01 1996-05-28 Optically active (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)-piperazin-1-yl]-phenoxy}-butiric acid as inhibitor of celle-adhesion, preparation and use of this compound, pharmaceutical composition containing this compound

Country Status (31)

Country Link
EP (1) EP0796247A1 (hu)
JP (1) JP2885941B2 (hu)
KR (1) KR100245957B1 (hu)
AT (1) AT406675B (hu)
AU (1) AU710105B2 (hu)
BE (1) BE1009520A5 (hu)
BR (1) BR9606409A (hu)
CA (1) CA2194397A1 (hu)
CH (1) CH691808A5 (hu)
CZ (1) CZ26997A3 (hu)
DE (1) DE19680509T1 (hu)
DK (1) DK10697A (hu)
ES (1) ES2137886B1 (hu)
FI (1) FI970393A (hu)
GB (1) GB2304340B (hu)
GR (1) GR1002702B (hu)
HU (1) HUP9700274A3 (hu)
IE (1) IE960405A1 (hu)
IL (1) IL118477A0 (hu)
IT (1) IT1290839B1 (hu)
LU (1) LU90008B1 (hu)
MC (1) MC2418A1 (hu)
MX (1) MX9700379A (hu)
NL (1) NL1003243C2 (hu)
NO (1) NO307460B1 (hu)
NZ (1) NZ308597A (hu)
PL (1) PL318440A1 (hu)
SE (1) SE510812C2 (hu)
SK (1) SK13097A3 (hu)
TR (1) TR199700020T1 (hu)
WO (1) WO1996038416A1 (hu)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
DK0825184T3 (da) * 1993-03-29 2001-09-10 Astrazeneca Ab Heterocykliske derivater som blodpladeaggregeringsinhibitorer
IL109145A0 (en) * 1993-03-29 1994-06-24 Zeneca Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
GB2304340B (en) 1998-07-29
WO1996038416A1 (en) 1996-12-05
AU710105B2 (en) 1999-09-16
KR970704689A (ko) 1997-09-06
FI970393A0 (fi) 1997-01-30
HUP9700274A3 (en) 2000-02-28
PL318440A1 (en) 1997-06-09
IE960405A1 (en) 1996-12-11
ITMI961113A1 (it) 1997-12-01
BR9606409A (pt) 1997-09-30
KR100245957B1 (ko) 2000-04-01
ATA900596A (de) 1999-12-15
SE9700203L (sv) 1997-01-24
HU9700274D0 (en) 1997-04-28
BE1009520A5 (fr) 1997-04-01
AT406675B (de) 2000-07-25
EP0796247A1 (en) 1997-09-24
ITMI961113A0 (it) 1996-05-31
SE510812C2 (sv) 1999-06-28
IL118477A0 (en) 1996-09-12
GR1002702B (el) 1997-05-22
CZ26997A3 (en) 1997-08-13
MX9700379A (es) 1997-04-30
JP2885941B2 (ja) 1999-04-26
TR199700020T1 (tr) 1997-04-22
FI970393A (fi) 1997-01-30
SE9700203D0 (sv) 1997-01-24
CA2194397A1 (en) 1996-12-05
DE19680509T1 (de) 1997-12-04
NO970437D0 (no) 1997-01-31
LU90008B1 (fr) 1997-04-16
NO307460B1 (no) 2000-04-10
NZ308597A (en) 1998-11-25
AU5827296A (en) 1996-12-18
JPH09512836A (ja) 1997-12-22
NL1003243C2 (nl) 1996-12-04
CH691808A5 (de) 2001-10-31
ES2137886B1 (es) 2000-08-16
IT1290839B1 (it) 1998-12-14
SK13097A3 (en) 1997-08-06
DK10697A (da) 1997-04-01
ES2137886A1 (es) 1999-12-16
GB9627127D0 (en) 1997-02-19
MC2418A1 (fr) 1997-05-23
GB2304340A (en) 1997-03-19
NO970437L (no) 1997-02-20

Similar Documents

Publication Publication Date Title
FR2742749B1 (fr) Nouvelles phenylimidazolidines comportant notamment un radical nitrooxy ou carbonyloxy, procede et intermediaires de preparation, application comme medicaments, nouvelles utilisations et compositions pharmaceutiques
CA2033392A1 (en) A-nor-steroid-3-carboxylic acid derivatives
FI956341A (fi) Metyylifosfonihappoesteri, menetelmä sen valmistamiseksi ja sen käyttö
PT1274698E (pt) Perciquinina, metodo para a sua producao e sua utilizacao como medicamento
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
CA2232374A1 (en) Phenylacetic acid derivatives, processes and intermediates for their preparation, and compositions comprising them
JPS57185275A (en) Tetrahydro-dum-4 and tetrahydro-isodum-4 and their derivatives
DK0696287T3 (da) Ureido-derivater af naphthalenphosphonsyrer og fremgangsmåde til deres fremstilling
ES472588A1 (es) Un procedimiento para la preparacion de un nuevo derivado deacido cicloalquilidenmetilfenilacetico
NZ318843A (en) Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
HUP9700274A2 (hu) Optikailag aktív (-)-(3R)-3-metil-4-{4-[4-(4-piridil)-piperazin-1-il]-fenoxi}-vajsav, mint sejtadhézió-inhibitor, előállítása és alkalmazása, a vegyületet tartalmazó gyógyászati készítmény
JPS5455542A (en) Peptides, their acid salts, and their preparation
ES8305750A1 (es) "procedimiento de preparacion de nuevas 2-(4-(difenilmetilen)-1-piperidinil)-acetamidas".
AU2926800A (en) Process for the preparation of a diol
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
GB1334693A (en) Acenaphthene derivatives
ES2104363T3 (es) Proceso para la preparacion de acido aminometanofosfonico.
ES371831A1 (es) Procedimiento para la preparacion de nuevos acidos ariloxi y ariltioaceticos sustituidos.
JPS5716855A (en) 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation
ATE206431T1 (de) Antifungal fusacandine
IT1276710B1 (it) Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
JPS5594382A (en) Chroman-based compound and cholestrol lowering drug comprising it
DE69820301D1 (de) Neue krystalline polymorphe form von 1-methyl-5-p-toluoylpyrrol-2-acetamidoessigsäure guaiacyl ester (med 15)
NO306155B1 (no) Nye fremgangsmÕter for fremstilling av (S)-4-amino-hepta-5,6-diensyre og mellomprodukter derav